Healthcare -
Biotechnology - NASDAQ - US
$ 4.4186
-5.79 %
$ 168 M
Market Cap
-2.76
P/E
OBIO - STOCK-BASED COMPENSATION
Stock-based Compensation OBIO - Orchestra BioMed Holdings, Inc.
7.62 M
LAST VALUE
402.48%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR